Selecta Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-0.11

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-13.98-7.15-4.97-3.06-0.91-2.02-4.39-14.504.62-471.095.36-0.91
Price/Sales ratio
59.2629.9722.26967.9665.9516.2318.474.381.47N/A2.0116.23
Price/Book Value ratio
-2.05-1.543.273.86-10.9912.91-17.0316.541.74-235.132.02-10.99
Price/Cash Flow ratio
-14.20-8.02-9.14-3.85-1.00-2.108.79-6.17-5.17-2.02K-5.99-2.10
Price/Free Cash Flow ratio
-13.95-7.62-8.87-3.79-0.99-2.109.00-6.06-4.98-2.01K-5.96-2.10
Price/Earnings Growth ratio
N/A-0.07-0.060.420.100.030.100.21-0.024.680.060.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%-540.15%-228.40%19.20%34.66%N/A41.78%41.78%
Operating Profit Margin
-506.54%-420.96%-428.92%-30813.52%-7200.66%-785.60%-342.35%-5.40%13.12%N/A15.46%-7200.66%
Pretax Profit Margin
-423.68%-418.79%-447.97%-31556.03%-7235.43%-828.96%-414.99%-11.42%31.38%N/A36.99%-7235.43%
Net Profit Margin
-423.68%-418.79%-447.97%-31556.03%-7235.43%-801.79%-420.47%-30.19%31.93%N/A37.64%-7235.43%
Effective Tax Rate
-3.94%-3.66%-1.25%-0.46%-1.80%3.27%-1.32%-164.24%-1.75%-7.95%1.75%-1.80%
Return on Assets
-57.94%-58.78%-40.54%-64.61%-146.88%-53.76%-42.18%-16.06%21.32%-72.02%21.32%-146.88%
Return On Equity
14.67%21.60%-65.88%-126.06%1205.90%-637.56%387.57%-114.05%37.70%49.91%43.66%43.66%
Return on Capital Employed
-118.48%-71.21%-45.86%-70.77%-696.31%-81.16%-67.73%-5.24%10.32%-36.48%10.32%-696.31%
Liquidity Ratios
Current Ratio
N/AN/A6.338.991.192.761.85N/AN/AN/A5.901.19
Quick Ratio
2.075.336.338.991.192.761.851.995.901.335.631.19
Cash ratio
1.794.434.276.431.062.571.701.574.241.124.241.06
Days of Sales Outstanding
80.9250.039.70111.08N/A273.32158.8642.5332.15N/A25.61273.32
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A0.00N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A273.32158.8642.5332.15N/AN/A273.32
Days of Payables Outstanding
N/AN/AN/AN/AN/A4.262.961.181.59N/AN/A4.26
Cash Conversion Cycle
N/AN/AN/AN/AN/A269.05155.9041.3430.55N/AN/A269.05
Debt Ratios
Debt Ratio
0.330.350.130.200.480.190.210.220.220.030.430.43
Debt Equity Ratio
-0.08-0.130.210.40-3.942.29-1.961.560.40-0.020.76-3.94
Long-term Debt to Capitalization
-0.05-0.110.120.28N/AN/A2.090.550.22-0.020.09N/A
Total Debt to Capitalization
-0.09-0.150.170.281.330.692.030.610.28-0.020.110.69
Interest Coverage Ratio
N/AN/A-27.66-52.88-43.52-34.53-36.51N/AN/AN/A4.79-43.52
Cash Flow to Debt Ratio
-1.71-1.47-1.63-2.47-2.76-2.660.98-1.71-0.83-4.67-2.71-2.76
Company Equity Multiplier
-0.25-0.361.621.95-8.2111.85-9.187.091.76-0.691.76-8.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.17-3.73-2.43-251.38-65.51-7.702.10-0.70-0.28N/A-0.33-65.51
Free Cash Flow / Operating Cash Flow Ratio
1.011.051.021.011.011.000.971.011.031.001.001.00
Cash Flow Coverage Ratio
-1.71-1.47-1.63-2.47-2.76-2.660.98-1.71-0.83-4.67-2.71-2.76
Short Term Coverage Ratio
-4.92-6.64-4.83N/A-2.76-2.6638.41-8.61-3.13-23.62-19.67-2.66
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A